English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Earendil Labs secures $787 million for AI-driven biologics development
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

FDA warns of seizure risk linked to Parkinson’s drugs with levodopa and carbidopa
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Kevin Tang appointed CEO as Aurinia Pharmaceuticals restructures leadership team
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Gene therapies for hearing loss show promise despite recent setbacks in the field
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

FDA’s new priority voucher program faces questions over transparency and selection process
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Study examines brain and muscle activity changes in aging and Parkinson’s during balance recovery
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Webinar to present Cancer Genome Interpreter tool for cancer genomics on April 9
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Researchers link mild hypoxia in preterm infants to lifelong memory problems

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes